Consolidative Therapy After EV + Pembrolizumab in Muscle Invasive Bladder Cancer, REINFORCE Trial
for Muscle Invasive Bladder Carcinoma
1 location in Seattle
Sponsor: University of Washington
Sex: All·Age: 18+
Code: NCT07579195·Phase 1, Phase 2·Not Yet Recruiting